Gene therapy in gynecological cancer

Rebecca A. Brooks, David G. Mutch

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Gynecological malignancies remain a major source of morbidity and mortality worldwide. In the USA alone, more than 77,000 women are diagnosed annually and over 28,000 die of some form of a gynecological malignancy. Many of these women will fail conventional therapy, leaving few remaining treatment options. Gene therapy presents one possible alternative treatment modality although, unfortunately, it is currently more theoretical than practical. Here, some of the basic science behind gene therapy is reviewed, different delivery systems used to transport the therapeutic gene are discussed, different methods of achieving a therapeutic effect are examined, some of the key trials in ovarian, endometrial, cervical and vulvar cancer research are highlighted and the future of gene therapy is explored.

Original languageEnglish (US)
Pages (from-to)1013-1032
Number of pages20
JournalExpert Review of Anticancer Therapy
Issue number7
StatePublished - Jul 2006
Externally publishedYes


  • Cancer
  • Cervical
  • Endometrial
  • Gene therapy
  • Gynecological
  • Ovarian
  • Vulvar

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Gene therapy in gynecological cancer'. Together they form a unique fingerprint.

Cite this